Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bangsberg

Showing results (31-40 of 390) with videos related to

Pageof 39
Sort By:
AIDS Research and Human Retroviruses|November 5, 2013
Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral loadJosé Peña, Norman G Jones, Stephanie Bousheri, et al.
International Health|December 25, 2013
Households with young children and use of freely distributed bednets in rural MadagascarPaul J Krezanoski, Alison B Comfort, Alexander C Tsai, et al.
AIDS and Behavior|February 22, 2012
Examining the applicability of the IMB model in predicting condom use among sexually active secondary school students in Mbarara, UgandaMichele L Ybarra, Josephine Korchmaros, Julius Kiwanuka, et al.
Plos One|September 30, 2009
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapyMichael Rosenblum, Steven G Deeks, Mark van der Laan, et al.
AIDS Care|February 4, 2012
Prevalence rates of sexual coercion victimization and perpetration among Uganda adolescentsMichele L Ybarra, Sheana S Bull, Julius Kiwanuka, et al.
HIV Clinical Trials|November 25, 2004
Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherenceSheri D Weiser, David Guzman, Elise D Riley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trialsMaya L Petersen, Yue Wang, Mark J van der Laan, et al.
AIDS Research and Therapy|April 6, 2017
Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?Catherine Orrell, Karen Cohen, Rory Leisegang, et al.
HIV Clinical Trials|April 30, 2004
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scaleThomas P Giordano, David Guzman, Richard Clark, et al.
AIDS (London, England)|February 16, 2012
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV preventionAriane van der Straten, Lut Van Damme, Jessica E Haberer, et al.
Pageof 39

Showing results (31-40 of 390) with videos related to

Sort By:
Pageof 39
AIDS Research and Human Retroviruses|November 5, 2013
Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral loadJosé Peña, Norman G Jones, Stephanie Bousheri, et al.
International Health|December 25, 2013
Households with young children and use of freely distributed bednets in rural MadagascarPaul J Krezanoski, Alison B Comfort, Alexander C Tsai, et al.
AIDS and Behavior|February 22, 2012
Examining the applicability of the IMB model in predicting condom use among sexually active secondary school students in Mbarara, UgandaMichele L Ybarra, Josephine Korchmaros, Julius Kiwanuka, et al.
Plos One|September 30, 2009
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapyMichael Rosenblum, Steven G Deeks, Mark van der Laan, et al.
AIDS Care|February 4, 2012
Prevalence rates of sexual coercion victimization and perpetration among Uganda adolescentsMichele L Ybarra, Sheana S Bull, Julius Kiwanuka, et al.
HIV Clinical Trials|November 25, 2004
Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherenceSheri D Weiser, David Guzman, Elise D Riley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trialsMaya L Petersen, Yue Wang, Mark J van der Laan, et al.
AIDS Research and Therapy|April 6, 2017
Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?Catherine Orrell, Karen Cohen, Rory Leisegang, et al.
HIV Clinical Trials|April 30, 2004
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scaleThomas P Giordano, David Guzman, Richard Clark, et al.
AIDS (London, England)|February 16, 2012
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV preventionAriane van der Straten, Lut Van Damme, Jessica E Haberer, et al.
Pageof 39